SHARE:  

Member Login

Join AHPA

MARKET ALERT

The American Herbal Products Association (AHPA) distributes member news and press releases as Market Alerts. The information presented in Market Alerts represents the views and opinions of the original authors of the content and does not necessarily represent the views or opinions of AHPA. Distribution of member news or a press release as a Market Alert does not constitute AHPA endorsement of the content. If you would like AHPA to distribute your press release, please email it to communications@ahpa.org.

Industry group objects to FTC substantiation policy

In an open letter to the Federal Trade Commission (FTC), several organizations have objected to the FTC requiring randomized clinical trials (RCTs) as supporting evidence for all health-related claims. The group contends that the FTC policy protects pharmaceuticals, not consumers. The initial group includes Alliance for Natural Health USA, a consumer advocacy group, along with several companies from the dietary supplement industry: Alkemist LabsNOW FoodsPrecision Patient OutcomesRidgeCrest Herbals, and Xlear. “People need to understand the costs and effects of this FTC policy”, said Matt Warnock, owner of RidgeCrest Herbals. “The FTC is applying the FDA drug approval standard to foods and supplements. It drives costs up for consumers, and protects drug companies.”

 

The letter can be seen at FreeMyHealth.org, a new website created to emphasize that these concerns are bigger than any one company or organization. The group is asking others to sign the letter as a show of solidarity and to make their voices heard. “We hope to gather signatures from every state in the union, and have hundreds of industry members speaking up about this,” Warnock said. “We’ll be presenting our concerns to Congress at the NPA Fly-In Day on May 22, 2024. We hope to see a big turn-out.”

 

The action comes after FTC sent a warning letter to 670 companies threatening fines of over $50,000 per day for unsubstantiated claims. "The letter didn't cite any alleged noncompliant claims," said Warnock, "so the unsubstantiated warning letter was the real threat to consumers. FTC's demands impose pointless costs on manufacturers, which consumers ultimately have to pay." 

Subscribe

Latest News

Events

Contact Us

Upcoming AHPA Events

AHPA Annual Fund Sponsors

Connect with AHPA

LinkedIn  Facebook  Instagram